Details
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 1073-1088 |
Seitenumfang | 16 |
Fachzeitschrift | Journal of Biopharmaceutical Statistics |
Jahrgang | 27 |
Ausgabenummer | 6 |
Frühes Online-Datum | 22 März 2017 |
Publikationsstatus | Elektronisch veröffentlicht (E-Pub) - 22 März 2017 |
Abstract
The identification of the minimum effective dose is of high importance in the drug development process. In early stage screening experiments, establishing the minimum effective dose can be translated into a model selection based on information criteria. The presented alternative, Bayesian variable selection approach, allows for selection of the minimum effective dose, while taking into account model uncertainty. The performance of Bayesian variable selection is compared with the generalized order restricted information criterion on two dose-response experiments and through the simulations study. Which method has performed better depends on the complexity of the underlying model and the effect size relative to noise.
ASJC Scopus Sachgebiete
- Mathematik (insg.)
- Statistik und Wahrscheinlichkeit
- Pharmakologie, Toxikologie und Pharmazie (insg.)
- Pharmakologie
- Medizin (insg.)
- Pharmakologie (medizinische)
Zitieren
- Standard
- Harvard
- Apa
- Vancouver
- BibTex
- RIS
in: Journal of Biopharmaceutical Statistics, Jahrgang 27, Nr. 6, 22.03.2017, S. 1073-1088.
Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review
}
TY - JOUR
T1 - Identification of the minimum effective dose for normally distributed data using a Bayesian variable selection approach
AU - Otava, Martin
AU - Shkedy, Ziv
AU - Hothorn, Ludwig A.
AU - Talloen, Willem
AU - Gerhard, Daniel
AU - Kasim, Adetayo
N1 - Funding Information: Martin Otava and Ziv Shkedy gratefully acknowledge the support from the IAP Research Network P7/06 of the Belgian State (Belgian Science Policy). Martin Otava gratefully acknowledge the financial support of the Research Project BOF11DOC09 of Hasselt University. The computational resources and services used in this work were provided by the VSC (Flemish Supercomputer Center), funded by the Hercules Foundation and the Flemish Government, department EWI. Martin Otava and Ziv Shkedy gratefully acknowledge the support from the IAP Research Network P7/06 of the Belgian State (Belgian Science Policy). Martin Otava gratefully acknowledge the financial support of the Research Project BOF11DOC09 of Hasselt University.
PY - 2017/3/22
Y1 - 2017/3/22
N2 - The identification of the minimum effective dose is of high importance in the drug development process. In early stage screening experiments, establishing the minimum effective dose can be translated into a model selection based on information criteria. The presented alternative, Bayesian variable selection approach, allows for selection of the minimum effective dose, while taking into account model uncertainty. The performance of Bayesian variable selection is compared with the generalized order restricted information criterion on two dose-response experiments and through the simulations study. Which method has performed better depends on the complexity of the underlying model and the effect size relative to noise.
AB - The identification of the minimum effective dose is of high importance in the drug development process. In early stage screening experiments, establishing the minimum effective dose can be translated into a model selection based on information criteria. The presented alternative, Bayesian variable selection approach, allows for selection of the minimum effective dose, while taking into account model uncertainty. The performance of Bayesian variable selection is compared with the generalized order restricted information criterion on two dose-response experiments and through the simulations study. Which method has performed better depends on the complexity of the underlying model and the effect size relative to noise.
KW - Bayesian variable selection
KW - minimum effective dose
KW - model selection
KW - model uncertainty
KW - order restricted models
UR - http://www.scopus.com/inward/record.url?scp=85015864653&partnerID=8YFLogxK
U2 - 10.1080/10543406.2017.1295247
DO - 10.1080/10543406.2017.1295247
M3 - Article
C2 - 28328286
AN - SCOPUS:85015864653
VL - 27
SP - 1073
EP - 1088
JO - Journal of Biopharmaceutical Statistics
JF - Journal of Biopharmaceutical Statistics
SN - 1054-3406
IS - 6
ER -